QL
COGT icon

Quarry LP’s Cogent Biosciences COGT Stock Holding History

Quarry LP’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,500
Closed -$10.1K – 1838
2024
Q1 		$10.1K Buy
1,500
+317
+27% +$1.96K ﹤0.01% 1186
2023
Q4 		$6.96K Buy
+1,183
New +$9.06K ﹤0.01% 1183

Other funds holding COGT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Quarry LP's COGT Position: Q2 2024 in Review

Quarry LP sold out of Cogent Biosciences (COGT) in Q2 2024, closing a stake of 1,500 shares — an estimated $10.1K sold.

Quarry LP first reported a position in COGT in Q4 2023 and held it in 2 quarters. The position peaked at $10.1K in Q1 2024. 148 funds tracked by Wall St. Rank hold COGT as of Q2 2024.

  • Quarry LP reported no remaining Cogent Biosciences position as of Q2 2024 after selling out during the quarter.
  • Quarry LP sold 1,500 Cogent Biosciences shares in Q2 2024, an estimated $10.1K.
  • Quarry LP first reported a position in Cogent Biosciences in Q4 2023 and held it in 2 quarters.
  • Quarry LP's Cogent Biosciences position peaked at $10.1K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2024.

Based on Quarry LP's 13F filing for Q2 2024, filed 14 Aug 2024.